Liquid biopsy guided precision therapy for lung cancers

Chongrui Xu, Michael Offin, Paul K. Paik, Bob T. Li


Wang et al. reported results of the BENEFIT trial sponsored by Chinese Thoracic Oncology Group (CTONG) in Lancet Respiratory Medicine, the first clinical trial conducted using circulating tumor DNA (ctDNA) for patient selection (1).

Download Citation